222 related articles for article (PubMed ID: 37293562)
1. Chemoprevention in oral leukoplakia: challenges and current landscape.
Palma VM; Koerich Laureano N; Frank LA; Rados PV; Visioli F
Front Oral Health; 2023; 4():1191347. PubMed ID: 37293562
[TBL] [Abstract][Full Text] [Related]
2. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders.
Viglianisi G; Polizzi A; Grippaudo C; Cocuzza S; Leonardi R; Isola G
Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247942
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of oral cancer in leukoplakia patients: A systematic review and meta-analysis.
Xie A; Liu J
J Pak Med Assoc; 2017 Sep; 67(9):1415-1419. PubMed ID: 28924285
[TBL] [Abstract][Full Text] [Related]
5. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2006 Oct; (4):CD001829. PubMed ID: 17054142
[TBL] [Abstract][Full Text] [Related]
6. [Chemoprevention of oral cancer--clinical and experimental studies].
Szumiło J; Podlodowska J; Podlodowski W; Starosławska E; Burdan F
Pol Merkur Lekarski; 2012 Feb; 32(188):138-42. PubMed ID: 22590920
[TBL] [Abstract][Full Text] [Related]
7. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of oral cancer: A review and future perspectives.
Liao YH; Chou WY; Chang CW; Lin MC; Wang CP; Lou PJ; Chen TC
Head Neck; 2023 Apr; 45(4):1045-1059. PubMed ID: 36810813
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive Synergism between Green Tea Extract and Curcumin in Patients with Potentially Malignant Oral Disorders: A Double-blind, Randomized Preliminary Study.
Neetha MC; Panchaksharappa MG; Pattabhiramasastry S; Shivaprasad NV; Venkatesh UG
J Contemp Dent Pract; 2020 May; 21(5):521-531. PubMed ID: 32690834
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia.
Garewal H
Eur J Cancer Prev; 1994 Mar; 3(2):101-7. PubMed ID: 8019381
[TBL] [Abstract][Full Text] [Related]
11. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2004; (3):CD001829. PubMed ID: 15266454
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of randomized trials for the treatment of oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
J Dent Educ; 2002 Aug; 66(8):896-902. PubMed ID: 12214837
[TBL] [Abstract][Full Text] [Related]
13. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
Nagao T; Warnakulasuriya S; Nakamura T; Kato S; Yamamoto K; Fukano H; Suzuki K; Shimozato K; Hashimoto S
Int J Cancer; 2015 Apr; 136(7):1708-17. PubMed ID: 25156040
[TBL] [Abstract][Full Text] [Related]
14. A review of the nonsurgical treatment of oral leukoplakia.
Ribeiro AS; Salles PR; da Silva TA; Mesquita RA
Int J Dent; 2010; 2010():186018. PubMed ID: 20339486
[TBL] [Abstract][Full Text] [Related]
15. Topical agents for oral cancer chemoprevention: A systematic review of the literature.
Chau L; Jabara JT; Lai W; Svider PF; Warner BM; Lin HS; Raza SN; Fribley AM
Oral Oncol; 2017 Apr; 67():153-159. PubMed ID: 28351570
[TBL] [Abstract][Full Text] [Related]
16. Oral leukoplakia - an update.
Parlatescu I; Gheorghe C; Coculescu E; Tovaru S
Maedica (Bucur); 2014 Mar; 9(1):88-93. PubMed ID: 25553134
[TBL] [Abstract][Full Text] [Related]
17. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
Meyskens FL
Ann N Y Acad Sci; 2001 Dec; 952():116-23. PubMed ID: 11795430
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of head and neck and lung (pre)cancer.
de Vries N; van Zandwijk N; Pastorino U
Recent Results Cancer Res; 1999; 151():13-25. PubMed ID: 10337716
[TBL] [Abstract][Full Text] [Related]
19. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2001; (4):CD001829. PubMed ID: 11687126
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of bladder cancer.
Kamat AM; Lamm DL
Urol Clin North Am; 2002 Feb; 29(1):157-68. PubMed ID: 12109342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
